Healthequity (HQY) Capital Expenditures (2013 - 2026)

Healthequity has reported Capital Expenditures for 14 years, with the latest figure at $14.8 million in Q3 2026.

• On a quarterly basis, Capital Expenditures rose 42.12% year-over-year to $14.8 million in Q3 2026; TTM through Jul 2026 was $50.8 million, a 2.86% decrease from a year earlier, with the FY2026 full-year figure at $46.5 million, down 9.02% from the prior year.
• Capital Expenditures was $14.8 million for Q3 2026 at Healthequity, down from $15.9 million in the prior quarter.
• The five-year high for Capital Expenditures was $16.1 million in Q2 2025, with the low at $9.0 million in Q2 2023.
• Average Capital Expenditures over 5 years is $12.0 million, with a median of $11.6 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Capital Expenditures sank 36.37% in 2022, then jumped 45.57% in 2024.
• Over 5 years, Capital Expenditures stood at $11.1 million in 2022, then climbed by 4.76% to $11.6 million in 2023, then gained by 8.19% to $12.6 million in 2024, then declined by 18.03% to $10.3 million in 2025, then jumped by 43.54% to $14.8 million in 2026.
• The last three Capital Expenditures figures came in at $14.8 million (Q3 2026), $15.9 million (Q2 2026), and $9.7 million (Q1 2026), per Business Quant data.